Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2013

01-09-2013 | Original Article

Chronic kidney disease in adolescent and adult patients with phenylketonuria

Authors: Julia B. Hennermann, Sylvia Roloff, Jutta Gellermann, Ilka Vollmer, Elke Windt, Barbara Vetter, Ursula Plöckinger, Eberhard Mönch, Uwe Querfeld

Published in: Journal of Inherited Metabolic Disease | Issue 5/2013

Login to get access

Abstract

Objectives

A lifelong phenylalanine-restricted diet with supplementation of a phenylalanine-free amino acid formula is recommended in patients with phenylketonuria (PKU). The effect of a long-term PKU diet on renal function and blood pressure has not been investigated yet.

Design

We analyzed renal function in 67 patients with PKU, aged 15–43 years, by measuring glomerular filtration rate (GFR) and effective renal plasma flow by isotope clearance (51Cr-EDTA, 123J-Hippuran), estimated GFR, blood retention parameters, urinary protein and electrolyte excretion. Renal ultrasound and 24 h ambulatory blood pressure monitoring were performed additionally. Patients were divided into three groups according to their: 1) current diet (CD), i.e., daily protein intake: ICD <0.8 g/kg, IICD 0.8–1.04 g/kg, IIICD >1.04 g/kg; 2) life-long diet time (LDT), i.e., cumulative years of life in which daily protein intake exceeded dietary recommendations: ILDT <15 years, IILDT 15–19 years, IIILDT >19 years.

Results

GFR was decreased in 19 % of the patients. With increasing protein intake, GFR decreased significantly (ICD 111 ml/min; IICD 105 ml/min; IIICD 99 ml/min. ILDT 112 ml/min; IILDT 103 ml/min; IIILDT 99 ml/min). Proteinuria was detected in 31 %, microalbuminuria in 7 %, and hypercalciuria in 23 % of the patients. 23 % of the patients had arterial hypertension, and 41 % revealed a nocturnal non-dipping status.

Conclusions

In patients with PKU on a lifelong diet we could detect impaired renal function in 19 %, proteinuria in 31 %, and arterial hypertension in 23 %. Thus, chronic kidney disease may develop in PKU patients, and routine renal function tests should be performed during long-term follow-up.
Appendix
Available only for authorised users
Literature
go back to reference Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenylketonuria. Eur J Pediatr 155(Suppl 1):S121–S124CrossRefPubMed Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenylketonuria. Eur J Pediatr 155(Suppl 1):S121–S124CrossRefPubMed
go back to reference Acosta PB, Yannicelli S, Marriage B et al (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291CrossRefPubMed Acosta PB, Yannicelli S, Marriage B et al (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291CrossRefPubMed
go back to reference Acosta PB, Yanicelli S, Singh R et al (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103:1167–1173CrossRefPubMed Acosta PB, Yanicelli S, Singh R et al (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103:1167–1173CrossRefPubMed
go back to reference Anderson PH, O’Loughlin PD, May BK, Morris HA (2004) Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 89–90:111–113CrossRefPubMed Anderson PH, O’Loughlin PD, May BK, Morris HA (2004) Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. J Steroid Biochem Mol Biol 89–90:111–113CrossRefPubMed
go back to reference Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, Deluca JM (2002) Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 141:243–246CrossRefPubMed Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, Deluca JM (2002) Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 141:243–246CrossRefPubMed
go back to reference Bernstein AM, Treyzon L, Li Z (2007) Are high-protein, vegetable based diets safe for kidney function? A review of the literature. J Am Diet Assoc 107:644–650CrossRefPubMed Bernstein AM, Treyzon L, Li Z (2007) Are high-protein, vegetable based diets safe for kidney function? A review of the literature. J Am Diet Assoc 107:644–650CrossRefPubMed
go back to reference Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307:652–659CrossRefPubMed Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307:652–659CrossRefPubMed
go back to reference Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774–1777CrossRefPubMed Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774–1777CrossRefPubMed
go back to reference Burgard P, Bremer HJ, Bührdel P et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158:46–54CrossRefPubMed Burgard P, Bremer HJ, Bührdel P et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158:46–54CrossRefPubMed
go back to reference Chaturvedi S, Jones C (2007) Protein restriction for children with chronic renal failure. Cochrane Database Syst Rev 17(4):CD006863 Chaturvedi S, Jones C (2007) Protein restriction for children with chronic renal failure. Cochrane Database Syst Rev 17(4):CD006863
go back to reference DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1985) Empfehlungen für die Nährstoffzufuhr: Umschau Verlag DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1985) Empfehlungen für die Nährstoffzufuhr: Umschau Verlag
go back to reference DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1991) Empfehlungen für die Nährstoffzufuhr: Umschau/Braus DGE Empfehlung: Deutsche Gesellschaft für Ernährung (1991) Empfehlungen für die Nährstoffzufuhr: Umschau/Braus
go back to reference D-A-CH Empfehlung: Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2000) Referenzwerte für die Nährstoffzufuhr: Umschau/Braus D-A-CH Empfehlung: Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2000) Referenzwerte für die Nährstoffzufuhr: Umschau/Braus
go back to reference Enomoto A, Niwa T (2007) Roles of organic anion transporters in the progression of chronic renal failure. Ther Apher Dial 11(Suppl 1):S27–S31CrossRefPubMed Enomoto A, Niwa T (2007) Roles of organic anion transporters in the progression of chronic renal failure. Ther Apher Dial 11(Suppl 1):S27–S31CrossRefPubMed
go back to reference Fouque D, Aparicio M (2007) Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol 3:383–392CrossRefPubMed Fouque D, Aparicio M (2007) Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol 3:383–392CrossRefPubMed
go back to reference German Nutrition Society (2012) New reference values for vitamin D. Ann Nutr Metab 60:241–246CrossRef German Nutrition Society (2012) New reference values for vitamin D. Ann Nutr Metab 60:241–246CrossRef
go back to reference Gropper SS, Gropper DM, Acosta PB (1993) Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr 16:143–150CrossRefPubMed Gropper SS, Gropper DM, Acosta PB (1993) Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr 16:143–150CrossRefPubMed
go back to reference Guldberg P, Rey F, Zschocke J et al (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71–79CrossRefPubMedPubMedCentral Guldberg P, Rey F, Zschocke J et al (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71–79CrossRefPubMedPubMedCentral
go back to reference Güttler F, Guldberg KF (1994) Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia. Acta Paediatr 407(Suppl):46–56 Güttler F, Guldberg KF (1994) Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia. Acta Paediatr 407(Suppl):46–56
go back to reference Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP (2009) Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 46:468–476CrossRefPubMed Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP (2009) Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 46:468–476CrossRefPubMed
go back to reference Halbesma N, Bakker SJ, Jansen DF et al (2009) High protein intake associates with cardiovascular events but not with loss of renal function. J Am Soc Nephrol 20:1797–1804CrossRefPubMedPubMedCentral Halbesma N, Bakker SJ, Jansen DF et al (2009) High protein intake associates with cardiovascular events but not with loss of renal function. J Am Soc Nephrol 20:1797–1804CrossRefPubMedPubMedCentral
go back to reference Hennermann JB, Vetter B, Wolf C et al (2000) Phenylketonuria and hyperphenylalaninemia in Eastern Germany: a characteristic molecular profile and 15 novel mutations. Hum Mut 15:254–260CrossRefPubMed Hennermann JB, Vetter B, Wolf C et al (2000) Phenylketonuria and hyperphenylalaninemia in Eastern Germany: a characteristic molecular profile and 15 novel mutations. Hum Mut 15:254–260CrossRefPubMed
go back to reference Hoeksma M, Van Rijn M, Verkerk PH et al (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28:845–854CrossRefPubMed Hoeksma M, Van Rijn M, Verkerk PH et al (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28:845–854CrossRefPubMed
go back to reference Hüseman D, Gellermann J, Vollmer I et al (1999) Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13:672–677CrossRefPubMed Hüseman D, Gellermann J, Vollmer I et al (1999) Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13:672–677CrossRefPubMed
go back to reference Itoh R, Nishiyama N, Suyama Y (1998) Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population. Am J Clin Nutr 67:438–444PubMed Itoh R, Nishiyama N, Suyama Y (1998) Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population. Am J Clin Nutr 67:438–444PubMed
go back to reference Jia Y, Hwang SY, House JD, Ogborn MR, Weiler HA, Karmin O, Aukema HM (2010) Long-term high intake of whole proteins results in renal damage in pigs. J Nutr 140: 1646–1652CrossRefPubMed Jia Y, Hwang SY, House JD, Ogborn MR, Weiler HA, Karmin O, Aukema HM (2010) Long-term high intake of whole proteins results in renal damage in pigs. J Nutr 140: 1646–1652CrossRefPubMed
go back to reference Kambham N, Markowitz GS, Valeri AM (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509CrossRefPubMed Kambham N, Markowitz GS, Valeri AM (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509CrossRefPubMed
go back to reference Kastarinen H, Vasunta RL, Ukkola O, Kesäniemi YA (2010) Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring—a cross-sectional population-based study. J Hum Hypertens 24:247–253CrossRefPubMed Kastarinen H, Vasunta RL, Ukkola O, Kesäniemi YA (2010) Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring—a cross-sectional population-based study. J Hum Hypertens 24:247–253CrossRefPubMed
go back to reference King AJ, Levey AS (1993) Dietary protein and renal function. J Am Soc Nephrol 3:1723–1737PubMed King AJ, Levey AS (1993) Dietary protein and renal function. J Am Soc Nephrol 3:1723–1737PubMed
go back to reference Kooman JP (2009) Estimation of renal function in patients with chronic kidney disease. J Magn Reson Imaging 30:1341–1346CrossRefPubMed Kooman JP (2009) Estimation of renal function in patients with chronic kidney disease. J Magn Reson Imaging 30:1341–1346CrossRefPubMed
go back to reference Krauch G, Müller E, Anninos A, Bremer HJ (1996) Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO expert consultation. Eur J Pediatr 155(Suppl 1):S153–S157CrossRefPubMed Krauch G, Müller E, Anninos A, Bremer HJ (1996) Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO expert consultation. Eur J Pediatr 155(Suppl 1):S153–S157CrossRefPubMed
go back to reference Kriz W (2004) Podocytes as a target for treatment with ACE inihibitors and/or angiotensin-receptor blockers. Kidney Int 65:333–334CrossRefPubMed Kriz W (2004) Podocytes as a target for treatment with ACE inihibitors and/or angiotensin-receptor blockers. Kidney Int 65:333–334CrossRefPubMed
go back to reference Lichter-Konecki U, Hipke CM, Konecki DS (1999) Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Mol Genet Metab 67:308–316CrossRefPubMed Lichter-Konecki U, Hipke CM, Konecki DS (1999) Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Mol Genet Metab 67:308–316CrossRefPubMed
go back to reference MacDonald A, Rocha JC, van Rijn M, Feillet F (2011) Nutrition in phenylketonuria. Mol Genet Metab 104(Suppl):S10–S18CrossRefPubMed MacDonald A, Rocha JC, van Rijn M, Feillet F (2011) Nutrition in phenylketonuria. Mol Genet Metab 104(Suppl):S10–S18CrossRefPubMed
go back to reference Manz F, Schmidt H, Schärer K, Bickel H (1977) Acid-base status in dietary treatment of phenylketonuria. Pediatr Res 11:1084–1087CrossRefPubMed Manz F, Schmidt H, Schärer K, Bickel H (1977) Acid-base status in dietary treatment of phenylketonuria. Pediatr Res 11:1084–1087CrossRefPubMed
go back to reference Mönch E, Herrmann ME, Brösicke H, Schöffer A, Keller M (1996) Utilisation of amino acid mixtures in adolescents with phenylketonuria. Eur J Pediatr 155(Suppl 1):S115–S120CrossRefPubMed Mönch E, Herrmann ME, Brösicke H, Schöffer A, Keller M (1996) Utilisation of amino acid mixtures in adolescents with phenylketonuria. Eur J Pediatr 155(Suppl 1):S115–S120CrossRefPubMed
go back to reference O’Brien E, Asmar R, Beilin L et al (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697–701CrossRefPubMed O’Brien E, Asmar R, Beilin L et al (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697–701CrossRefPubMed
go back to reference Parati G, Pickering TG (2009) Home blood-pressure monitoring: US and European consensus. Lancet 373:876–878CrossRefPubMed Parati G, Pickering TG (2009) Home blood-pressure monitoring: US and European consensus. Lancet 373:876–878CrossRefPubMed
go back to reference Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653–662CrossRefPubMed Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653–662CrossRefPubMed
go back to reference Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77–83CrossRefPubMed Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77–83CrossRefPubMed
go back to reference Scriver CR, Kaufman S (2001) Phenylalanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly W, Valle D, Childs B, Vogelstein B (eds). The metabolic and molecular basis of inherited disease. McGraw-Hill, 1667–1724 Scriver CR, Kaufman S (2001) Phenylalanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly W, Valle D, Childs B, Vogelstein B (eds). The metabolic and molecular basis of inherited disease. McGraw-Hill, 1667–1724
go back to reference Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73CrossRefPubMed Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73CrossRefPubMed
go back to reference Sitta A, Barschak AG, Deon M et al (2009) L-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211–218CrossRefPubMed Sitta A, Barschak AG, Deon M et al (2009) L-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211–218CrossRefPubMed
go back to reference Staples A, LeBlond R, Watkins S, Wong C, Brandt J (2010) Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol 25:2321–2326CrossRefPubMed Staples A, LeBlond R, Watkins S, Wong C, Brandt J (2010) Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol 25:2321–2326CrossRefPubMed
go back to reference White JE, Kronmal RA, Acosta PB (1982) Excess weight among children with phenylketonuria. J Am Coll Nutr 1:293–303CrossRefPubMed White JE, Kronmal RA, Acosta PB (1982) Excess weight among children with phenylketonuria. J Am Coll Nutr 1:293–303CrossRefPubMed
go back to reference Wingen AM, Fabian-Bach C, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European study group of nutritional treatment of chronic renal failure in childhood. Lancet 349:1117–1123CrossRefPubMed Wingen AM, Fabian-Bach C, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European study group of nutritional treatment of chronic renal failure in childhood. Lancet 349:1117–1123CrossRefPubMed
go back to reference Wühl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) German working group on pediatric hypertension: distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007CrossRefPubMed Wühl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) German working group on pediatric hypertension: distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007CrossRefPubMed
go back to reference Zager RA, Johannes G, Tuttle SE, Sharma HM (1983) Acute amino acid nephrotoxicity. J Lab Clin Med 101:130–140PubMed Zager RA, Johannes G, Tuttle SE, Sharma HM (1983) Acute amino acid nephrotoxicity. J Lab Clin Med 101:130–140PubMed
go back to reference Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Publ Health 8:117CrossRef Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Publ Health 8:117CrossRef
go back to reference Zhao YY, Liu J, Cheng XL, Bai X, Lin RC (2012) Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413:642–649CrossRefPubMed Zhao YY, Liu J, Cheng XL, Bai X, Lin RC (2012) Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413:642–649CrossRefPubMed
Metadata
Title
Chronic kidney disease in adolescent and adult patients with phenylketonuria
Authors
Julia B. Hennermann
Sylvia Roloff
Jutta Gellermann
Ilka Vollmer
Elke Windt
Barbara Vetter
Ursula Plöckinger
Eberhard Mönch
Uwe Querfeld
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9548-0

Other articles of this Issue 5/2013

Journal of Inherited Metabolic Disease 5/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.